0.4853
11.61%
+0.0505
Dare Bioscience Inc Azioni (DARE) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
1.00
|
- | - | - | - |
Operating Expenses
|
4.53%
9.3964
|
8.9894 | 8.3826 | 16.23 | 7.1388 |
Benefits Costs and Expenses |
-
|
- | - | 40.95 | - |
Costs And Expenses |
9.3964
|
- | - | 15.79 | - |
Operating Income/Loss |
6.60%
-8.3964
|
-8.9894 | -8.3826 | -16.23 | -7.1388 |
Income/Loss From Continuing Operations Before Tax |
111.41%
1.00
|
-8.7622 | -8.0425 | -40.95 | -7.0198 |
Income/Loss From Continuing Operations After Tax |
5.29%
-8.2991
|
-8.7622 | -8.0425 | -15.94 | -7.0198 |
Net Income/Loss
|
5.29%
-8.2991
|
-8.7622 | -8.0425 | -15.94 | -7.0198 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
5.38%
91.05
|
86.40 | 85.52 | -0.9813 | 84.82 |
Diluted Average Shares |
5.38%
91.05
|
86.40 | 85.52 | -0.9813 | 84.82 |
Basic Earnings Per Share |
10.00%
-0.09
|
-0.10 | -0.09 | -0.19 | -0.08 |
Diluted Earnings Per Share |
10.00%
-0.09
|
-0.10 | -0.09 | -0.19 | -0.08 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Capitalizzazione:
|
Volume (24 ore):